Trends in antidepressant overdoses

Debate continues about antidepressants and suicide. However, there are few recent nation‐wide data about antidepressant overdoses. The purpose of this study was to describe United States trends from 1983 through 2003 in antidepressant overdoses as well as trends in health care utilization and mortality.

[1]  A. Simmons,et al.  Case of self-poisoning with multiple antidepressant drugs. , 1970, Lancet.

[2]  Poisoning by tricyclic drugs. , 1972, British medical journal.

[3]  T. Litovitz,et al.  1983 annual report of the American Association of Poison Control Centers National Data Collection System. , 1984, The American journal of emergency medicine.

[4]  T. Litovitz,et al.  1985 Annual Report of the American Association of Poison Control Centers National Data Collection System. , 1986, The American journal of emergency medicine.

[5]  T. Litovitz,et al.  1986 annual report of the American Association of Poison Control Centers National Data Collection System. , 1987, The American journal of emergency medicine.

[6]  T. Litovitz,et al.  1987 annual report of the American Association of Poison Control Centers National Data Collection System. , 1988, The American journal of emergency medicine.

[7]  T. Litovitz,et al.  1988 annual report of the American Association of Poison Control Centers National Data Collection System. , 1989, The American journal of emergency medicine.

[8]  T. Litovitz,et al.  1989 annual report of the American association of poison control centers national data collection system , 1990 .

[9]  S. Kapur,et al.  The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. , 1991, Archives of general psychiatry.

[10]  T. Litovitz,et al.  1990 annual report of the American Association of Poison Control Centers National Data Collection System. , 1991, The American journal of emergency medicine.

[11]  M. Stanley,et al.  Antidepressants and Suicide Risk: Issues of Chemical and Behavioral Toxicity , 1992, Journal of clinical psychopharmacology.

[12]  A. Leon,et al.  The effect of access to lethal methods of injury on suicide rates. , 1992, Archives of general psychiatry.

[13]  T. Litovitz,et al.  1991 annual report of the American Association of Poison Control Centers National Data Collection System. , 1992, The American journal of emergency medicine.

[14]  T. Litovitz,et al.  1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1993, The American journal of emergency medicine.

[15]  The toxicity and dose of desipramine hydrochloride. , 1994, JAMA.

[16]  T. Litovitz,et al.  1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1999, The American journal of emergency medicine.

[17]  D. D'mello,et al.  The cost of antidepressant overdose. , 1995, General hospital psychiatry.

[18]  H. Jick,et al.  Antidepressants and suicide , 1995, BMJ.

[19]  J. Henry,et al.  Relative mortality from overdose of antidepressants , 1995, BMJ.

[20]  T. Litovitz,et al.  1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1995, The American journal of emergency medicine.

[21]  I. Anderson,et al.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis , 1995, BMJ.

[22]  T. Litovitz,et al.  1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1996, The American journal of emergency medicine.

[23]  S. R. Rose,et al.  2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2003, The American journal of emergency medicine.

[24]  D A Zarin,et al.  Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. , 1998, JAMA.

[25]  S. Roose,et al.  SSRI safety in overdose. , 1998, The Journal of clinical psychiatry.

[26]  D. Sclar,et al.  Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995. , 1998, Clinical therapeutics.

[27]  T. Litovitz,et al.  1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1998, The American journal of emergency medicine.

[28]  N. Freemantle,et al.  North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group. , 1999, Family practice.

[29]  A. House,et al.  Deliberate self poisoning with antidepressant drugs: a comparison of the relative hospital costs of cases of overdose of tricyclics with those of selective-serotonin re-uptake inhibitors. , 2000, Journal of affective disorders.

[30]  M. Whooley,et al.  Managing depression in medical outpatients. , 2000, The New England journal of medicine.

[31]  J. Rose,et al.  A mortality index for postmarketing surveillance of new medications. , 2000, The American journal of emergency medicine.

[32]  T. Litovitz,et al.  1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2000, The American journal of emergency medicine.

[33]  T. Litovitz,et al.  2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2001, The American journal of emergency medicine.

[34]  J. Markowitz.  Antidepressants and suicide risk , 2001, British Journal of Psychiatry.

[35]  A. Woolf,et al.  2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2002, The American journal of emergency medicine.

[36]  H. Leufkens,et al.  Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands , 2002, Pharmacoepidemiology and Drug Safety.

[37]  Harold Alan Pincus,et al.  National trends in the outpatient treatment of depression. , 2002, JAMA.

[38]  Adrienne Z. Ables,et al.  Antidepressants: update on new agents and indications. , 2003, American family physician.

[39]  C. Foxcroft,et al.  Prescribing patterns of tricyclic and selective serotonin reuptake inhibitor antidepressants among a sample of adolescents and young adults , 2003, Pharmacoepidemiology and drug safety.

[40]  M. Olfson,et al.  Relationship between antidepressant medication treatment and suicide in adolescents. , 2003, Archives of general psychiatry.

[41]  M. Hotopf,et al.  Economic Evaluation of Antidepressive Agents: A Systematic Critique of Experimental and Observational Studies , 2003, Journal of clinical psychopharmacology.

[42]  I. Whyte,et al.  Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. , 2003, QJM : monthly journal of the Association of Physicians.

[43]  S. R. Rose,et al.  2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2003, The American journal of emergency medicine.

[44]  A. Leon,et al.  Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998. , 2004, The Journal of clinical psychiatry.

[45]  H. Jick,et al.  Antidepressants and the risk of suicidal behaviors. , 2004, JAMA.

[46]  Douglas Borys,et al.  2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2004, The American journal of emergency medicine.

[47]  FDA to review “missing” drug company documents , 2004, BMJ : British Medical Journal.

[48]  D. Gunnell,et al.  Antidepressants and suicide: what is the balance of benefit and harm , 2004, BMJ : British Medical Journal.

[49]  Peter Fonagy,et al.  Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data , 2004, The Lancet.

[50]  M. Oquendo,et al.  Antidepressants and suicide risk in the United States, 1985-1999. , 2004, The Journal of clinical psychiatry.

[51]  Robert D Gibbons,et al.  The relationship between antidepressant medication use and rate of suicide. , 2005, Archives of general psychiatry.

[52]  K. Hawton,et al.  Deliberate self-harm in children and adolescents: a research update , 2005, Current opinion in psychiatry.

[53]  D. Gunnell,et al.  Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study , 2005, BMJ : British Medical Journal.

[54]  S. Zuvekas.  Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001. , 2005, Health affairs.

[55]  Klaus P. Ebmeier,et al.  Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants , 2005 .

[56]  D. Gunnell,et al.  Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review , 2005, BMJ : British Medical Journal.

[57]  Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials , 2005, BMJ : British Medical Journal.

[58]  D. Mines,et al.  Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram , 2005, Pharmacoepidemiology and drug safety.

[59]  A. Flanagan,et al.  2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1994, The American journal of emergency medicine.

[60]  J. Geddes,et al.  Suicide, depression, and antidepressants , 2005, BMJ : British Medical Journal.

[61]  D. Klein,et al.  The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children , 2006, Neuropsychopharmacology.

[62]  J. Savarino,et al.  Suicide risk during antidepressant treatment. , 2006, The American journal of psychiatry.

[63]  D. Redelmeier,et al.  The risk of suicide with selective serotonin reuptake inhibitors in the elderly. , 2006, The American journal of psychiatry.

[64]  J. Racoosin,et al.  Suicidality in pediatric patients treated with antidepressant drugs. , 2006, Archives of general psychiatry.

[65]  R. Baldessarini,et al.  Suicidal risk in antidepressant drug trials. , 2006, Archives of general psychiatry.

[66]  J. Racoosin,et al.  Suicide Rates in Short-term Randomized Controlled Trials of Newer Antidepressants , 2006, Journal of clinical psychopharmacology.